At a glance
ClinicalIndex Comparison RecordN/ACompleted· 162 enrolled
Drug / intervention
Emervel Deep Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds
In Brief
A clinical study evaluating Emervel Deep Lidocaine and Juvederm Ultra Plus for Skin Wrinkling. Completed, enrolled 162 participants across 11 sites.
Detailed Summary
The purpose of the study was to compare the effectiveness and safety of Emervel Deep Lidocaine versus Juvederm Ultra Plus in the treatment of moderate to severe facial wrinkles and folds.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Wrinkling
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2010
Enrollment StartSep 2010
Primary CompletionJun 2011
Study CompletionJan 2012
TodayJul 2026
First PostedSep 20, 2010
Enrollment StartSep 27, 2010
Primary CompletionJun 20, 2011
Study CompletionJan 12, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.8 years ago
Interventions
Emervel Deep Lidocainedevice
20 mg/mL + 0.3% lidocaine
Juvederm Ultra Plusdevice
24mg/mL